• 1
    Zackrisson B, Aus G, Bergdahl S et al. The risk of finding focal cancer (less than 3 mm) remains high on re-biopsy of patients with persistently increased prostate specific antigen but the clinical significance is questionable. J Urol 2004; 171: 15003
  • 2
    Stewart CS, Leibovich BC, Weaver AL, Lieber MM. Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. J Urol 2001; 166: 8692
  • 3
    Fleshner N, Klotz L. Role of ‘saturation biopsy’ in the detection of prostate cancer among difficult diagnostic cases. Urology 2002; 60: 937
  • 4
    Amsellem-Ouazana D, Younes P, Conquy S et al. Negative prostatic biopsies in patients with a high risk of prostate cancer. Is the combination of endorectal MRI and magnetic resonance spectroscopy imaging (MRSI) a useful tool? A preliminary study. Eur Urol 2005; 47: 5826
  • 5
    Beyersdorff D, Taupitz M, Winkelmann B et al. Patients with a history of elevated prostate-specific antigen levels and negative transrectal US-guided quadrant or sextant biopsy results: value of MR imaging. Radiology 2002; 224: 7016
  • 6
    Perrotti M, Han KR, Epstein RE et al. Prospective evaluation of endorectal magnetic resonance imaging to detect tumor foci in men with prior negative prostatic biopsy: a pilot study. J Urol 1999; 162: 13147
  • 7
    Yuen JS, Thng CH, Tan PH et al. Endorectal magnetic resonance imaging and spectroscopy for the detection of tumor foci in men with prior negative transrectal ultrasound prostate biopsy. J Urol 2004; 171: 14826
  • 8
    Ikonen S, Kivisaari L, Tervahartiala P, Vehmas T, Taari K, Rannikko S. Prostatic MR imaging. Accuracy in differentiating cancer from other prostatic disorders. Acta Radiol 2001; 42: 34854
  • 9
    White S, Hricak H, Forstner R et al. Prostate cancer: effect of postbiopsy hemorrhage on interpretation of MR images. Radiology 1995; 195: 38590
  • 10
    Mullerad M, Hricak H, Kuroiwa K et al. Comparison of endorectal magnetic resonance imaging, guided prostate biopsy and digital rectal examination in the preoperative anatomical localization of prostate cancer. J Urol 2005; 174: 215863
  • 11
    Noworolski SM, Henry RG, Vigneron DB, Kurhanewicz J. Dynamic contrast-enhanced MRI in normal and abnormal prostate tissues as defined by biopsy, MRI, and 3D MRSI. Magn Reson Med 2005; 53: 24955
  • 12
    Padhani AR, Gapinski CJ, Macvicar DA et al. Dynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumour stage, histological grade and PSA. Clin Radiol 2000; 55: 99109
  • 13
    Futterer JJ, Heijmink SW, Scheenen TW et al. Prostate cancer: local staging at 3-T endorectal MR imaging – early experience. Radiology 2006; 238: 18491
  • 14
    Littrup PJ, Williams CR, Egglin TK, Kane RA. Determination of prostate volume with transrectal US for cancer screening. Part II. Accuracy of in vitro and in vivo techniques. Radiology 1991; 179: 4953
  • 15
    Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986; 73: 1322
  • 16
    Efron B, Tibshirani RJ. An Introduction to the Bootstrap. New York: Chapman & Hall, 1993
  • 17
    Bono AV, Celato N, Cova V, Salvadore M, Chinetti S, Novario R. Microvessel density in prostate carcinoma. Prostate Cancer Prostatic Dis 2002; 5: 1237
  • 18
    Shih SJ, Dall’Era MA, Westphal JR et al. Elements regulating angiogenesis and correlative microvessel density in benign hyperplastic and malignant prostate tissue. Prostate Cancer Prostatic Dis 2003; 6: 1317
  • 19
    Siegal JA, Yu E, Brawer MK. Topography of neovascularity in human prostate carcinoma. Cancer 1995; 75: 254551
  • 20
    Wefer AE, Hricak H, Vigneron DB et al. Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology. J Urol 2000; 164: 4004